-
2022-502778-18-00
5
2023-11-17
ulcerative colitis
-
2022-502540-12-00
5
2023-11-09
Refractory Status Epilepticus (RSE)
-
2022-502678-18-00
5
2023-11-07
Type 2 diabetes
-
2022-502552-31-00
4
2023-10-03
Relapsing Forms of Multiple Sclerosis
-
2022-502782-14-00
5
2023-09-28
Heterozygous Familial Hypercholesterolemia (HeFH)
-
2023-503576-25-00
5
2023-09-22
Severe Hypertriglyceridemia
-
2022-502196-31-00
10
2023-08-21
Advanced or Recurrent Endometrial Cancer
-
2022-502023-21-00
5
2023-07-12
Prevention of pregnancy
-
2022-502024-51-00
5
2023-07-12
Prevention of pregnancy
-
2022-500535-36-01
5
2023-06-12
Moderately to severely active ulcerative colitis
-
2023-509747-27-00
4
2023-05-18
Heart failure
-
2023-509746-35-00
4
2023-05-16
Primary Discoid Lupus Erythematosus
-
2022-501078-20-00
4
2023-05-15
Metastatic Castration-resistant Prostate Cancer
-
2024-513591-18-00
5
2023-04-26
Postmenopausal osteoporosis
-
2023-506352-24-00
5
2023-04-13
Non-obstructive Hypertrophic Cardiomyopathy
-
2022-500228-31-01
10
2023-03-31
Knee osteoarthritis pain
-
2023-505902-40-00
4
2023-03-28
Heart Failure with Preserved Ejection Fraction
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2024-513230-38-00
5
2022-12-15
Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peri
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2023-509508-13-00
1
2022-10-04
Various solid tumors that are metastatic or unresectable
-
2024-513992-42-00
10
2022-09-13
venous thromboembolism (VTE) in patients with gastrointestinal/genitou
-
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
-
2023-504441-31-00
7
2022-06-29
gastric adenocarcinoma or adenocarcinoma of the gastroesophageal junct